https://www.selleckchem.com/B-Raf.html
76), respectively. The 5-year event-free survival was 52.94% (95% CI 41.83, 62.87). In multivariate analysis, the independent prognostic factors were presence of metastasis and completion of treatment for both 5-year and 10-year overall survival. Good histological response was only significant for multivariate analysis at 5 years. Patients with metastasis had a hazard ratio of 20.4 at 5 years and 3.26 at 10 years. CONCLUSION Overall survival rate for osteosarcoma patients at our centre was comparably higher than other centres in the region. Two in
Like
Comment
Share
